New hope for diabetes patients: drug may strengthen bones and prevent breaks
NCT ID NCT07063797
First seen Jan 06, 2026 · Last updated May 13, 2026 · Updated 19 times
Summary
This study tests whether the drug denosumab can help prevent bone fractures in people with type 2 diabetes who are at high risk for osteoporosis. About 358 adults aged 50 and older (or postmenopausal women aged 45+) will receive denosumab or a placebo. The goal is to see if the drug improves bone density and reduces the chance of new fractures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Huai'an First People's Hospital
Huai'an, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Jiangxi Provincial People's Hospital
Jiangxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kunshan Hospital of Traditional Chinese Medicine
Kunshan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Peking Union Medical College Hospital
Beijing, Dongcheng, 100730, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.